Teva Pharmaceutical Industries

Aktuelle Nachrichten

Schlagzeilen in der Originalsprache der Quelle.

• Teva Presents New Efficacy and Safety Data with Ecopipam, an Investigational Treatment for Pediatric Patients with Tourette Syndrome (öffnet in neuem Tab)

  Yahoo Finance UK · 02.10.2026

• TD Cowen Initiates Coverage on Teva Pharmaceutical Industries (NYSE:TEVA) (öffnet in neuem Tab)

  MarketBeat · 01.10.2026

• Branded Medicines and Pipeline Successes Drive Teva Pharmaceutical Industries’ (TEVA) Margin Expansion (öffnet in neuem Tab)

  Yahoo Finance · 01.10.2026

• TD Cowen Initiates Teva Pharmaceutical Industries at Buy With $55 Price Target (öffnet in neuem Tab)

  Yahoo Finance · 01.10.2026

• Teva Pharmaceutical and Samsung Bioepis Forge Global Biosimilar Partnership (TEVA) (öffnet in neuem Tab)

  GuruFocus · 01.10.2026

• Samsung Bioepis, Teva expand biosimilar pact to target US and Europe - CHOSUNBIZ (öffnet in neuem Tab)

  Chosunbiz · 01.10.2026

• Samsung Bioepis, Teva enter commercialization agreement on 6 biosimilar candidates (öffnet in neuem Tab)

  The Korea Times · 01.10.2026

• Teva Pharmaceutical Industries Limited (TEVA) Stock Price, News, Quote & History (öffnet in neuem Tab)

  Yahoo! Finance Canada · 01.10.2026

• Teva names Serge Rogasik as CEO of API, CDMO business (öffnet in neuem Tab)

  TradingView · 30.09.2026

• Samsung Bioepis and Teva Expand Strategic Partn… | UNI India (öffnet in neuem Tab)

  uniindia.com · 30.09.2026

• Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Receives Average Rating of "Moderate Buy" from Analysts (öffnet in neuem Tab)

  MarketBeat · 30.09.2026

• Teva's Branded Drugs Take Center Stage in Its Growth Strategy (öffnet in neuem Tab)

  TradingView · 29.09.2026

• Teva Pharmaceutical: 3 Numbers That Explain This Generic-Drug Turnaround (öffnet in neuem Tab)

  fool.com · 29.09.2026

• Teva Pharmaceutical Industries (NYSE:TEVA) Stock Forecast & Analyst Predictions (öffnet in neuem Tab)

  Simply Wall Street · 29.09.2026

• Teva Pharmaceutical Industries Gains FDA Nod for Degevma Biosimi (öffnet in neuem Tab)

  GuruFocus · 28.09.2026

• Form 4 TEVA PHARMACEUTICAL INDUSTRIES LTD For: 27 September By Investing.com (öffnet in neuem Tab)

  Investing.com Canada · 27.09.2026

• Teva to Host Conference Call to Discuss Third Quarter 2026 Financial Results on November 3, 2026 at 8 a.m. ET (öffnet in neuem Tab)

  riauone.com · 24.09.2026

• Teva Pharmaceutical Industries stock trades 4.36 percent below its yearly high (öffnet in neuem Tab)

  AD HOC NEWS · 24.09.2026

• Teva releases Q3 2026 Aide Memoire ahead of November earnings (öffnet in neuem Tab)

  scanx.trade · 23.09.2026

• Teva Pharmaceutical Industries Ltd. to Report Third Quarter 2026 Financial Results on November 3, 2026 (öffnet in neuem Tab)

  Quiver Quantitative · 23.09.2026

• Third-quarter results are set for 7 a.m.; Teva's call follows at 8. (öffnet in neuem Tab)

  Stock Titan · 23.09.2026

• Teva Releases Q3 2026 Aide Memoire (öffnet in neuem Tab)

  GlobeNewswire · 23.09.2026

• Oppenheimer Initiates Coverage on Teva Pharmaceutical Industries (NYSE:TEVA) (öffnet in neuem Tab)

  MarketBeat · 23.09.2026

• Teva Eyes New Growth Phase After Securing Investment-Grade Ratings (öffnet in neuem Tab)

  TradingView · 23.09.2026

• Brian Savage Sells 7,342 Shares of Teva Pharmaceutical Industries (NYSE:TEVA) Stock (öffnet in neuem Tab)

  MarketBeat · 22.09.2026

• Teva Pharmaceutical Industries (NYSE:TEVA) Director Roberto Mignone Sells 367,600 Shares (öffnet in neuem Tab)

  MarketBeat · 22.09.2026

• Director’s fund exits Teva Pharmaceutical Industries (TEVA) stake in one-day sale (öffnet in neuem Tab)

  Stock Titan · 22.09.2026

• Teva CEO Details Biopharma Pivot, $700M Savings Plan and Growth Pipeline (öffnet in neuem Tab)

  Yahoo Finance · 22.09.2026

• Teva Pharmaceutical Industries (TEVA), Why Is It Back In The Spotlight? (öffnet in neuem Tab)

  Yahoo Finance · 21.09.2026

• Teva (NYSE: TEVA) legal chief files $273K share-sale notice (öffnet in neuem Tab)

  Stock Titan · 21.09.2026